8-K: LivaNova Shareholders Approve Key Incentive Plans and Re-Elect Board at 2025 Annual General Meeting

LivaNova PLC shareholders overwhelmingly approved the Second Amended and Restated 2022 Incentive Award Plan and the 2025 Director Incentive Award Plan, alongside the re-election of all ten directors and other governance proposals, at their Annual General Meeting on June 11, 2025.

Summary

• LivaNova PLC held its 2025 Annual General Meeting (AGM) on June 11, 2025, with approximately 83.59% of outstanding shares represented, constituting a quorum.
• Shareholders approved the Second Amended and Restated LivaNova PLC 2022 Incentive Award Plan, which authorizes an aggregate of 2,200,000 shares for awards to employees.
• The 2025 Director Incentive Award Plan was also approved, making a total of 300,000 shares available for equity-based compensation to non-executive directors, succeeding the 2015 Plan.
• All ten nominated directors, including J. Christopher Barry, Francesco Bianchi, Stacy Enxing Seng, William A. Kozy, Vladimir Makatsaria, Dr. Sharon O'Kane, Susan Podlogar, Todd Schermerhorn, Brooke Story, and Peter Wilver, were re-elected for terms expiring at the 2026 AGM.
• Shareholders provided advisory approval for the compensation of named executive officers and ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2025.
• The company also received authorization for directors to allot shares up to a nominal amount of £10,904,831 and approved the disapplication of pre-emption rights for a similar amount.
• Advisory approval was given for the UK directors' remuneration report and the directors' remuneration policy for the period ended December 31, 2024.
• The audited UK statutory accounts for the year ended December 31, 2024, were received and adopted, and PricewaterhouseCoopers LLP was re-appointed as the UK statutory auditor for 2025, with remuneration determination authorized to the directors or Audit and Compliance Committee.

Sentiment

Score: 8

Explanation: The document reflects a highly positive sentiment due to the unanimous approval of all proposals at the AGM, including significant incentive award plans for employees and directors, and the re-election of the entire board. This indicates strong shareholder confidence and a stable governance environment, which are favorable indicators for the company's operational continuity and strategic execution.

Positives

• Overwhelming shareholder support for all 12 proposals, indicating strong confidence in the company's governance and compensation strategies.
• Approval of the Second Amended and Restated 2022 Incentive Award Plan provides a robust framework for motivating and retaining employees through equity awards, aligning their interests with shareholders.
• The new 2025 Director Incentive Award Plan enhances the company's ability to attract and retain high-caliber non-executive directors by offering competitive equity-based compensation.
• The re-election of all incumbent directors ensures continuity and stability in the company's leadership.
• Ratification of the independent auditor and approval of remuneration policies demonstrate adherence to sound corporate governance practices.

Risks

• The value of performance stock units (PSUs), restricted stock units (RSUs), and stock appreciation rights (SARs) can increase or decrease based on market price fluctuations of LivaNova shares.
• Holders of equity awards are responsible for all applicable tax liabilities, which may exceed amounts withheld by the company, and the company does not guarantee any particular tax result.
• Forfeiture of unvested awards can occur upon termination of service, with specific conditions for approved retirement, good leaver terminations, or termination for cause.
• Certain activities, including material breach of fiduciary, confidentiality, non-disclosure, non-competition, non-solicitation, non-interference, or non-disparagement obligations, can lead to immediate forfeiture of unvested awards.
• Inability to execute market sell orders for shares due to legal/contractual restrictions, market disruptions, or Nasdaq rules could leave holders responsible for timely tax payments.
• Shares acquired through awards may be subject to lock-up periods in certain jurisdictions (e.g., two years in Belgium, six months in Singapore, and a holding period in France), restricting immediate sale.

Future Outlook

The approval of the Second Amended and Restated 2022 Incentive Award Plan and the 2025 Director Incentive Award Plan provides LivaNova with updated frameworks for attracting, motivating, and retaining key talent and non-executive directors through equity-based compensation, supporting future performance and shareholder value creation. The plans are designed to align employee and director interests with those of the company's shareholders.

Industry Context

The approval of these incentive award plans is a standard practice for publicly traded companies, particularly in the medical technology sector, to ensure competitive compensation structures that attract and retain top talent. Such plans are crucial for aligning the interests of employees and directors with long-term shareholder value, a common trend across industries focused on innovation and growth.

Management Changes

Corporate Governance

Stakeholder Impact

• **Shareholders:** Benefit from the approval of incentive plans designed to align employee and director interests with long-term shareholder value. The re-election of directors and approval of governance matters indicate stability and continuity.
• **Employees:** Will benefit from the Second Amended and Restated 2022 Incentive Award Plan, which provides opportunities for equity ownership and performance-based compensation, enhancing motivation and retention.
• **Non-Executive Directors:** Will benefit from the 2025 Director Incentive Award Plan, offering equity-based compensation that aligns their oversight responsibilities with the company's performance and shareholder returns.
• **Management:** The approval of compensation plans and re-election of directors provides a clear mandate and stable environment for executing the company's strategy.

Next Steps

• Implementation of the Second Amended and Restated LivaNova PLC 2022 Incentive Award Plan for employees.
• Implementation of the LivaNova PLC 2025 Director Incentive Award Plan for non-executive directors.
• Continued operation under the approved directors' remuneration policy.
• Preparation for the next Annual General Meeting in 2026, where directors' terms will expire.

Key Dates

Recommendation

Keywords

LivaNova PLC, SEC Filing, 8-K, Annual General Meeting, Incentive Award Plan, Equity Compensation, Performance Stock Units, Restricted Stock Units, Stock Appreciation Rights, Corporate Governance, Shareholder Approval, Director Elections, Executive Compensation, Auditor Ratification, Share Allotment, Pre-emption Rights, Remuneration Report